Incentives for Global Health
Jump to navigation
Jump to search
Incentives for Global Health
The Health Impact Fund, "our flagship proposal, is a new way of stimulating research and development of life-saving pharmaceuticals. To provide wide access, medicines need to be affordable-but low prices don't create strong incentives for innovators to invest in research and development. The Health Impact Fund is an optional mechanism that offers pharmaceutical innovators a supplementary reward based on the health impact of their products, if they agree to sell those products at cost. The proposed Fund is to be financed mainly by governments." [1]
Support and Affiliations:
- Australian Research Council
- BUPA Foundation, UK
- Centre for Applied Philosophy and Public Ethics (CAPPE), Australian National University
- Gilberts LLP, Canada
Contents
Management Team
Accessed February 2010: [2]
- Thomas Pogge, President, Director
- Aidan Hollis, Vice President, Director
- Tim Gilbert, Director
- Matt Peterson, Chief Financial Officer
- Dave Goodman, Secretary
- David Franklin, Pro Bono Legal Advisor
- Surjeet Ahluwalia, Senior Project Manager
Advisory Board
Accessed February 2010: [3]
- John J. DeGioia
- Ruth Faden
- Paul Farmer
- Jim Yong Kim
- Christopher Murray
- Onora O'Neill
- James Orbinski
- Sir Michael Rawlins
- Amartya Sen
- Peter Singer
- Judith Whitworth
- Heidemarie Wieczorek-Zeul
- Richard Wilder
Contact
URL: http://www.yale.edu/macmillan/igh/
